Company Incyte Corporation

Equities

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
56.97 USD -0.26% Intraday chart for Incyte Corporation -1.30% -9.27%

Business Summary

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows:

- product sales (85.6%);

- royalties (14.2%);

- income from research and cooperation agreements (0.2%).

Number of employees: 2,524

Sales per Business

USD in Million2022Weight2023Weight Delta
Proprietary Therapeutics
100.0 %
3,395 100.0 % 3,696 100.0 % +8.87%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
95.1 %
3,200 95.6 % 3,500 95.1 % +9.38%
Europe and Japan
4.9 %
-- 179 4.9 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 64 14-01-12
Director of Finance/CFO 53 19-02-10
President 60 23-06-04
Chief Tech/Sci/R&D Officer 57 15-03-01
Investor Relations Contact - 23-08-31
General Counsel 58 23-09-30
Comptroller/Controller/Auditor 46 05-05-31
Corporate Officer/Principal - 15-07-31
Corporate Officer/Principal - 15-12-31
Corporate Officer/Principal 51 16-04-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 57 00-12-31
Director/Board Member 71 19-12-15
Director/Board Member 70 15-01-19
Director/Board Member 64 21-09-26
Director/Board Member 62 17-11-13
Director/Board Member 62 15-01-19
Director/Board Member 57 22-09-30
Chief Executive Officer 64 14-01-12
Director/Board Member 72 20-03-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 224,526,128 220,968,122 ( 98.42 %) 0 98.42 %

Shareholders

NameEquities%Valuation
Baker Bros. Advisors LP
16.11 %
36,179,122 16.11 % 2 111 M $
Vanguard Fiduciary Trust Co.
10.03 %
22,519,381 10.03 % 1 314 M $
BlackRock Advisors LLC
8.724 %
19,588,229 8.724 % 1 143 M $
Dodge & Cox
7.166 %
16,090,421 7.166 % 939 M $
10,120,170 4.507 % 591 M $
Renaissance Technologies LLC
2.474 %
5,553,937 2.474 % 324 M $
Geode Capital Management LLC
1.903 %
4,273,448 1.903 % 249 M $
BlackRock Life Ltd.
1.809 %
4,061,794 1.809 % 237 M $
Eaton Vance Management
1.495 %
3,355,698 1.495 % 196 M $
Société Générale Asset Management (Japan) Co., Ltd.
1.360 %
3,052,505 1.360 % 178 M $

Holdings

NameEquities%Valuation
4,004,544 6.94% 194,140,293 $

Company contact information

Incyte Corp.

1801 Augustine Cut-Off

19803, Wilmington

+302 498 6700

http://www.incyte.com
address Incyte Corporation(INCY)